[1]
2022. The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma. Journal of Pharmaceutical Negative Results. 13, 3 (Sep. 2022), 20–25. DOI:https://doi.org/10.47750/pnr.2022.13.03.004.